|
|
|
41
|
1691B
|
THIORIDAZINE 10MG TAB (MAT)
|
THIORIDAZINE
|
THIORIDAZINE
|
100'S
|
A
|
221.9
|
2.219
|
TAB
|
360
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160824
|
PHENOTHIAZINES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PHENOTHIAZINES
|
|
|
|
|
42
|
1691B
|
THIORIDAZINE 10MG TAB (MAT)
|
THIORIDAZINE
|
THIORIDAZINE
|
100'S
|
A
|
221.90
|
2.22
|
TAB
|
360
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160824
|
PHENOTHIAZINES
|
2026-04-01
|
|
|
ORAL
|
6
|
PHENOTHIAZINES
|
|
|
|
|
41
|
1692M
|
THIORIDAZINE 25MG TAB (MAT)
|
THIORIDAZINE
|
THIORIDAZINE
|
100'S
|
A
|
312.06
|
3.1206
|
TAB
|
360
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160824
|
PHENOTHIAZINES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PHENOTHIAZINES
|
|
|
|
|
42
|
1692M
|
THIORIDAZINE 25MG TAB (MAT)
|
THIORIDAZINE
|
THIORIDAZINE
|
100'S
|
A
|
312.06
|
3.12
|
TAB
|
360
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160824
|
PHENOTHIAZINES
|
2026-04-01
|
|
|
ORAL
|
6
|
PHENOTHIAZINES
|
|
|
|
|
42
|
1693C
|
THIORIDAZINE 50MG TAB (MAT)
|
THIORIDAZINE
|
THIORIDAZINE
|
1000'S
|
A
|
364.42
|
0.36
|
TAB
|
300
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160824
|
PHENOTHIAZINES
|
2026-04-01
|
|
|
ORAL
|
6
|
PHENOTHIAZINES
|
|
|
|
|
42
|
17016
|
TRIFLUOPERAZINE 1MG TAB (MAT)
|
TRIFLUOPERAZINE
|
TRIFLUOPERAZINE
|
1000'S
|
A
|
153.01
|
0.15
|
TAB
|
252
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160824
|
PHENOTHIAZINES
|
2026-04-01
|
|
|
ORAL
|
6
|
PHENOTHIAZINES
|
|
|
|
|
40
|
22827
|
ACETAZOLAMIDE 500MG INJ (MAT/AHI)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
500MG VIAL
|
BQ
|
182.67
|
182.67
|
INJECTION
|
0
|
VIAL
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
22827
|
ACETAZOLAMIDE 500MG INJ (MAT)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
500MG VIAL
|
BQ
|
182.89
|
182.8888
|
VIAL
|
10
|
VIAL
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
42
|
22827
|
ACETAZOLAMIDE 500MG INJ (MAT)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
500MG VIAL
|
BQ
|
189.39
|
189.39
|
VIAL
|
10
|
VIAL
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
|
|
IV
|
0
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
42
|
2592AM
|
FAMOTIDINE 10MG/ML INJ (MAT)
|
FAMOTIDINE
|
FAMOTIDINE
|
25X2 ML
|
BQ
|
129.80
|
5.19
|
AMPG
|
0
|
AMP
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2026-04-01
|
|
|
IV
|
0
|
HISTAMINE RECEPTOR ANTAGONIST
|
|
|
|
|
42
|
2593DU
|
SUCRALFATE 1G TAB (MAT)
|
SUCRALFATE
|
SUCRALFATE
|
100'S
|
A
|
83.81
|
0.84
|
TAB
|
120
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
562832
|
GI PROTECTANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
GI PROTECTANTS
|
|
|
|
|
40
|
A681AM
|
EFAVIRENZ | EMTRICITABINE | TENOFOVIR 600MG | 200MG | 300MG TAB (MAT/AHI)
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
27.59
|
0.92
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
A681AM
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MAT (BL)
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
30.17
|
1.0058
|
TAB
|
60
|
BOX
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
42
|
A681AM
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MAT
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
EFAVIRENZ|EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
27.59
|
0.92
|
TAB
|
60
|
BLIS
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
40
|
A681HB
|
ZOVILAM 150MG | 300MG TAB (MAT/AHI) LAMIVUDINE | ZIDOVUDINE
|
LAMIVUDINE|ZIDOVUDINE
|
ZOVILAM
|
60'S
|
BL
|
21.20
|
0.35
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
A681HB
|
ZOVILAM 150MG|300MG TAB (MAT) LAMIVUDINE|ZIDOVUDINE (BL)
|
LAMIVUDINE|ZIDOVUDINE
|
ZOVILAM
|
60'S
|
BL
|
30.17
|
0.5029
|
TAB
|
60
|
BOX
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
42
|
A681HD
|
ATAZANAVIR|RITONAVIR 300MG|100MG TA
|
ATAZANAVIR|RITONAVIR
|
ATAZANAVIR|RITONAVIR
|
30'S
|
BL
|
61.16
|
2.04
|
TAB
|
60
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2026-04-01
|
|
|
ORAL
|
0
|
NRTI
|
|
|
|
|
40
|
A681HE
|
ABACAVIR | LAMIVUDINE 600MG | 300MG TAB (MAT/AHI)
|
ABACAVIR|LAMIVUDINE
|
ABACAVIR|LAMIVUDINE
|
30'S
|
BL
|
63.61
|
2.12
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
A681HK
|
LOPINAVIR | RITONAVIR 200MG | 50MG TAB (MAT/AHI)
|
LOPINAVIR|RITONAVIR
|
LOPINAVIR|RITONAVIR
|
120'S
|
BL
|
85.63
|
0.71
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
A681HL
|
EMTRICITABINE | TENOFOVIR 200MG | 300MG TAB (MAT/AHI)
|
EMTRICITABINE|TENOFOVIR
|
EMTRICITABINE|TENOFOVIR
|
30'S
|
BL
|
29.19
|
0.97
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
